Position in ABBV
as of Jun 30, 2026
· filed Jul 1, 2026
Position Value
$80,186,344
-$1,336,519 QoQ
Shares Held
318,655
-15.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
1.65%
of 13F equity value
Holder Rank
#291
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EASTERN BANK holds $295,354,591 across 16 Drug Manufacturers - General names. ABBV ranks #2 (27.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
116,336 | $139,536,899 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
318,655 | $80,186,344 | |
| 3 | JNJ |
Johnson & Johnson
|
145,368 | $36,919,110 | |
| 4 | MRK |
Merck & Co., Inc.
|
191,760 | $24,641,159 | |
| 5 | NVO |
Novo Nordisk A S
|
122,583 | $5,876,628 | |
| 6 | PFE |
Pfizer Inc
|
88,290 | $2,126,023 | |
| 7 | AMGN |
Amgen Inc
|
4,449 | $1,611,071 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
27,740 | $1,598,378 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $80,186,344 | 318,655 | Shares | Defined | 2026-07-01 | |
| 2026-03-31 | $81,522,863 | 374,835 | Shares | Defined | 2026-04-07 | |
| 2025-12-31 | $86,933,361 | 380,469 | Shares | Defined | 2026-01-14 | |
| 2025-09-30 | $87,519,341 | 377,988 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $69,887,785 | 376,510 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $77,982,086 | 372,194 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $51,562,142 | 290,164 | Shares | Defined | 2025-01-13 | |
| 2024-09-30 | $41,920,066 | 212,275 | Shares | Defined | 2024-10-21 | |
| 2024-06-30 | $22,936,339 | 133,724 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $23,726,900 | 130,296 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $18,837,067 | 121,553 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $18,697,488 | 125,436 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $16,864,152 | 125,170 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $16,776,081 | 105,265 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $15,758,104 | 97,507 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $13,026,019 | 97,057 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $14,678,700 | 95,839 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $3,758,519 | 23,185 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $1,147,108 | 8,472 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $902,116 | 8,363 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $942,007 | 8,363 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $915,107 | 8,456 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $963,813 | 8,995 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $790,411 | 9,024 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $899,622 | 9,163 | Shares | Sole | 2020-09-01 | |
| 2020-03-31 | $713,670 | 9,367 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||